Management of classical Hodgkin lymphoma: a look at up to date evidence and current treatment approaches
Abstract The treatment landscape of classical Hodgkin lymphoma (cHL) has undergone significant changes over the past 20 years. Gradual improvements have been made in the management of cHL patients, particularly in prolonging the survival rate for those in the relapsed setting. Most of these improvem...
| 出版年: | Experimental Hematology & Oncology |
|---|---|
| 主要な著者: | , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
BMC
2022-12-01
|
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1186/s40164-022-00360-4 |